Latest News and Press Releases
Want to stay updated on the latest news?
-
LONDON, May 17, 2022 (GLOBE NEWSWIRE) -- Older oil and gas facilities have been more at risk of unplanned downtime. These also may contribute to excess greenhouse emissions. Using predictive...
-
New York, US, May 17, 2022 (GLOBE NEWSWIRE) -- Polyvinyl Alcohol (PVA) Market Overview According to a Comprehensive Research Report by Market Research Future (MRFR), “Polyvinyl Alcohol (PVA)...
-
- Enrollment completed in older adults portion of Phase 1/1b trial of IVX-121, a virus like particle (VLP) vaccine candidate displaying the prefusion stabilized Respiratory Syncytial Virus (RSV) F...
-
Newark, NJ, May 16, 2022 (GLOBE NEWSWIRE) -- As per the report published by Fior Markets, The global Cryo-electron Microscopy market is expected to grow from USD 540.51 million in 2019 to USD...
-
Albany NY, United States, May 16, 2022 (GLOBE NEWSWIRE) -- The value of the global decorative laminates market surpassed US$ 47.4 Bn in 2019 and the market is likely to rise at a CAGR of 6% during...
-
New York, May 16, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Nebulizers Global Market Report 2022" - https://www.reportlinker.com/p06277160/?utm_source=GNW The...
-
- Expanded Coverage for EYSUVIS® to 92% of Total Commercial Lives and 30% of All Medicare Lives - - Achieved 18% EYSUVIS Prescription Growth in 1Q 2022 - - Presented KPI-012 Phase 1b...
-
Closed initial public offering of 2,222,222 shares of common stock at a public offering price of $9.00 per share, with aggregate gross proceeds of approximately $20 millionMultiple vaccine candidate...
-
CAMBRIDGE, Mass., May 12, 2022 (GLOBE NEWSWIRE) -- Checkmate Pharmaceuticals, Inc. (Nasdaq: CMPI) (“Checkmate”), a clinical stage biopharmaceutical company focused on developing its proprietary...
-
Richland WA, May 12, 2022 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc is pleased to report that it expanded its intellectual property protection on several fronts. Our patent team filed...